A Real-World Study of JT001 for COVID-19

Active, not recruitingOBSERVATIONAL
Enrollment

7,656

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
COVID-19
Interventions
DRUG

JT001

oral administration

Trial Locations (6)

100034

Peking university first hospital, Beijing

200000

Shanghai Fourth People's Hospital, Shanghai

200032

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

200135

Gongli Hospital, Pudong New Area, Shanghai, Shanghai

201100

Central Hospital of Minhang District, Shanghai, Shanghai

201200

Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center, Shanghai

All Listed Sponsors
lead

Shanghai Vinnerna Biosciences Co., Ltd.

INDUSTRY

NCT06142201 - A Real-World Study of JT001 for COVID-19 | Biotech Hunter | Biotech Hunter